Drug Shortage Report for ATRIANCE

Last updated on 2018-08-28 History
Report ID 56126
Drug Identification Number 02299925
Brand name ATRIANCE
Common or Proper name ATRIANCE INJ 5MG/ML 50ML X 6
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) NELARABINE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50ML X 6
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-08-31
Actual start date
Estimated end date 2018-09-04
Actual end date 2018-08-28
Shortage status Avoided shortage
Updated date 2018-08-28
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-07-20 English Compare
v2 2018-07-20 French Compare
v3 2018-08-16 English Compare
v4 2018-08-16 English Compare
v5 2018-08-16 French Compare
v6 2018-08-28 English Compare
v7 2018-08-28 English Compare
v8 2018-08-28 French Compare